We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,214
Reduced
3,562
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAQ.U
9326
DELISTED
Generation Asia I Acquisition Limited Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
GAQ.U
$4.01K ﹤0.01%
400
TWNI.U
9327
DELISTED
Tailwind International Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TWNI.U
$4K ﹤0.01%
396
+300
+313% +$3K
CRVS icon
9328
Corvus Pharmaceuticals
CRVS
$1.17B
$4K ﹤0.01%
4,700
-17,956
-79% -$15.9K
CYTH
9329
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$3.99K ﹤0.01%
+2,810
New +$4.64K
NEXI
9330
DELISTED
NexImmune, Inc. Common Stock
NEXI
$3.99K ﹤0.01%
665
+80
+14% +$998
RETO icon
9331
ReTo Eco-Solutions
RETO
0
BIMI
9332
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$3.98K ﹤0.01%
3,240
+635
+24% +$1.54K
TCOA
9333
DELISTED
Zalatoris Acquisition Corp.
TCOA
$3.98K ﹤0.01%
396
-1,104
-74% -$11K
MURFU
9334
DELISTED
Murphy Canyon Acquisition Corp. Unit
MURFU
$3.98K ﹤0.01%
390
AHI
9335
DELISTED
Advanced Health Intelligence Ltd
AHI
$3.98K ﹤0.01%
2,426
-1,042
-30% -$1.81K
VMCAU
9336
DELISTED
Valuence Merger Corp. I Unit
VMCAU
$3.98K ﹤0.01%
382
BNED icon
9337
Barnes & Noble Education
BNED
$439M
$3.97K ﹤0.01%
23
-52
-69% -$12.4K
MAMB
9338
Monarch Ambassador Income Index ETF
MAMB
$193M
$3.96K ﹤0.01%
183
-265
-59% -$5.67K
SLNH icon
9339
Soluna Holdings
SLNH
$186M
$3.96K ﹤0.01%
610
+354
+138% +$8.71K
SGII
9340
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
$3.96K ﹤0.01%
389
-1,985
-84% -$20K
BODI icon
9341
The Beachbody Company
BODI
$79.2M
$3.96K ﹤0.01%
150
+130
+650% +$5.64K
TNON icon
9342
Tenon Medical
TNON
$3.33M
$3.96K ﹤0.01%
+31
New +$4.52K
VS icon
9343
Versus Systems
VS
$8.45M
$3.96K ﹤0.01%
505
+412
+443% +$14.2K
YDKG
9344
Yueda Digital Holding
YDKG
$5.97M
$3.96K ﹤0.01%
+36
New +$8.53K
IFBD icon
9345
Infobird
IFBD
$8.35M
$3.95K ﹤0.01%
8
+3
+60% +$2.14K
KZIA
9346
Kazia Therapeutics
KZIA
$137M
$3.94K ﹤0.01%
127
+50
+65% +$1.88K
STRR
9347
Star Equity Holdings
STRR
$42.5M
$3.94K ﹤0.01%
174
EUCRU
9348
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$3.94K ﹤0.01%
+400
New +$3.99K
INVZ icon
9349
Innoviz Technologies
INVZ
$88.8M
$3.93K ﹤0.01%
1,000
-9,950
-91% -$47.4K
IVCPU
9350
DELISTED
Swiftmerge Acquisition Corp. Unit
IVCPU
$3.93K ﹤0.01%
389

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.